[Maintenance doses of vecuronium and pancuronium during hypothermic cardiopulmonary bypass].
In 31 patients undergoing coronary artery bypass grafting, we investigated the maintenance doses of pancuronium and vecuronium during hypothermic cardiopulmonary bypass. For all patients, the height of the first twitch of the train-of-four (T1) was measured with evoked electromyogram. During operation, T1 was kept from 5 to 15 per cent of control. Infusion doses of both muscle relaxants were controlled with a personal computer. During hypothermic cardiopulmonary bypass (body temperature 28 degrees C), requirement of both muscle relaxants decreased for about 90 per cent compared with pre bypass values. We consider that the prolongation of neuromuscular blockade is attributable to hypothermia rather than to other factors of cardiopulmonary bypass. After rewarming, maintenance dose of vecuronium remained about a half of the dose required in pre-bypass period. It suggests that elimination of vecuronium from liver and kidney is hindered not only during hypothermia but also after rewarming.
Ohnishi
Y
Y
Department of Anesthesiology, National Cardiovascular Center, Suita.
Uchida
O
O
Nakajima
T
T
Kitaguchi
K
K
Takaki
O
O
Ohsumi
H
H
Kuro
M
M
D002315:Cardiopulmonary Bypass; D001026:Coronary Artery Bypass; D004576:Electromyography; D005260:Female; D006801:Humans; D007036:Hypothermia, Induced; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D010197:Pancuronium / Q000008:administration & dosage*; D014673:Vecuronium Bromide / Q000008:administration & dosage*
D014673:Vecuronium Bromide; D010197:Pancuronium